Ophthalmological Devices
Aug 27, 2026
Spineart and eCential Robotics Gain FDA Clearance for PERLA® TL Robotic Surgery Application; ZEISS CLINIC 360 Earns FDA 510(k) Clearance, Strengthening Data-Driven Patient Care; Bittium Introduces Faros Pro™ and EasyFlex™ for Extended Ambulatory ECG Monitoring; Cytrellis Expands ellacor® Micro-Coring® Technology to Australia for Full-Body Skin Resurfacing; Galmed Announces Successful First-in-Human Study of Colospan’s Novel Tissue Assessment Technology; FastWave Medical Secures FDA IDE Approval for Pivotal Artero™ Peripheral IVL Trial
Spineart and eCential Robotics Received FDA 510(k) Clearance for the PERLA® TL Application for Use with eCential® Op.n® Navigation System for Robotic Procedures On 26 August 2026, Spineart and eCential Robotics received FDA 510(k) clearance for the PERLA TL application for use with eCential Robotics’ Op.n ...
Read More...
Aug 20, 2026
Empatica Secures FDA Clearance for Parkinson’s Monitoring; ZEISS CLINIC 360 Secures FDA 510(k) Clearance; BioLab Holdings Strengthens Tissue Restoration Portfolio With Addition of FastSkin® Technology; Surity™ Expands Urinary Incontinence Care Portfolio with New At-Home Urinary Management System; Galmed Announces Positive First-in-Human Proof-of-Concept Results for Colospan’s Intraoperative Tissue Assessment Platform; FastWave Medical Secures FDA IDE Approval for Pivotal Artero™ Peripheral IVL Trial
Empatica Received FDA Clearance for Parkinson's Monitoring On 19 August 2026, Empatica announced that its Health Monitoring Platform for Parkinson’s disease had received 510(k) clearance from the U.S. Food and Drug Administration. The clearance expanded Empatica’s clinical-grade monitoring capabilities int...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
